|
1
|
Eagle RC Jr, Chévez-Barrios P, Li B, Al
Hussaini M and Wilson M: Retinoblastoma. In: WHO classification of
tumours of the eye. Grossniklaus HE, Eberhart CG and Kivelä TT
(eds). 4th edition. International Agency for Research on Cancer,
Lyon, pp111-117, 2018.
|
|
2
|
Kleinerman RA, Schonfeld SJ, Sigel BS,
Wong-Siegel JR, Gilbert ES, Abramson DH, Seddon JM, Tucker MA and
Morton LM: Bone and soft-tissue sarcoma risk in long-term survivors
of hereditary retinoblastoma treated with radiation. J Clin Oncol.
37:3436–3445. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Temming P, Arendt M, Viehmann A, Eisele L,
Le Guin CH, Schündeln MM, Biewald E, Astrahantseff K, Wieland R,
Bornfeld N, et al: Incidence of second cancers after radiotherapy
and systemic chemotherapy in heritable retinoblastoma survivors: A
report from the German reference center. Pediatr Blood Cancer.
64:71–80. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wong FL, Boice JD Jr, Abramson DH, Tarone
RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N,
Fraumeni JF Jr and Li FP: Cancer incidence after retinoblastoma.
Radiation dose and sarcoma risk. JAMA. 278:1262–1267.
1997.PubMed/NCBI View Article : Google Scholar
|
|
5
|
1000 Genomes Project Consortium. Auton A,
Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL,
McCarthy S, McVean GA and Abecasis GR: A global reference for human
genetic variation. Nature. 526:68–74. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Karczewski KJ, Francioli LC, Tiao G,
Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A,
Birnbaum DP, et al: The mutational constraint spectrum quantified
from variation in 141,456 humans. Nature. 581:434–443.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chakravarty D, Gao J, Phillips SM, Kundra
R, Zhang H, Wang J, Rudolph JE, Yaeger R, Soumerai T, Nissan MH, et
al: OncoKB: A precision oncology knowledge base. JCO Precis Oncol.
2017(PO.17.00011)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tamborero D, Rubio-Perez C, Deu-Pons J,
Schroeder MP, Vivancos A, Rovira A, Tusquets I, Albanell J, Rodon
J, Tabernero J, et al: Cancer Genome Interpreter annotates the
biological and clinical relevance of tumor alterations. Genome Med.
10(25)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Landrum MJ, Lee JM, Benson M, Brown GR,
Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Jang W, et al:
ClinVar: Improving access to variant interpretations and supporting
evidence. Nucleic Acids Res. 46:D1062–D1067. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tate JG, Bamford S, Jubb HC, Sondka Z,
Beare DM, Bindal N, Boutselakis H, Cole CG, Creatore C, Dawson E,
et al: COSMIC: The catalogue of somatic mutations in cancer.
Nucleic Acids Res. 47:D941–D947. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang K, Li M and Hakonarson H: ANNOVAR:
Functional annotation of genetic variants from high-throughput
sequencing data. Nucleic Acids Res. 38(e164)2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Knudson AG Jr: Mutation and cancer:
Statistical study of retinoblastoma. Proc Natl Acad Sci USA.
68:820–823. 1971.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Knudson AG: Two genetic hits (more or
less) to cancer. Nat Rev Cancer. 1:157–162. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Singh J, Mishra A, Pandian AJ, Mallipatna
AC, Khetan V, Sripriya S, Kapoor S, Agarwal S, Sankaran S,
Katragadda S, et al: Next-generation sequencing-based method shows
increased mutation detection sensitivity in an Indian
retinoblastoma cohort. Mol Vis. 22:1036–1047. 2016.PubMed/NCBI
|
|
15
|
Schieffer KM, Feldman AZ, Kautto EA,
McGrath S, Miller AR, Hernandez-Gonzalez ME, Lahaye S, Miller KE,
Koboldt DC, Brennan P, et al: Molecular classification of a complex
structural rearrangement of the RB1 locus in an infant with
sporadic, isolated, intracranial, sellar region retinoblastoma.
Acta Neuropathol Commun. 9(61)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
UniProt Consortium: UniProt: A worldwide
hub of protein knowledge. Nucleic Acids Res. 47:D506–D515.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Navarro Gonzalez J, Zweig AS, Speir ML,
Schmelter D, Rosenbloom KR, Raney BJ, Powell CC, Nassar LR,
Maulding ND, Lee CM, et al: The UCSC genome browser database: 2021
update. Nucleic Acids Res. 49:D1046–D1057. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dommering CJ, Marees T, van der Hout AH,
Imhof SM, Meijers-Heijboer H, Ringens PJ, van Leeuwen FE and Moll
AC: RB1 mutations and second primary malignancies after hereditary
retinoblastoma. Fam Cancer. 11:225–233. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Schaefer IM, Lundberg MZ, Demicco EG,
Przybyl J, Matusiak M, Chibon F, Ingram DR, Hornick JL, Wang WL,
Bauer S, et al: Relationships between highly recurrent tumor
suppressor alterations in 489 leiomyosarcomas. Cancer.
127:2666–2673. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chudasama P, Mughal SS, Sanders MA,
Hübschmann D, Chung I, Deeg KI, Wong SH, Rabe S, Hlevnjak M,
Zapatka M, et al: Integrative genomic and transcriptomic analysis
of leiomyosarcoma. Nat Commun. 9(144)2018.PubMed/NCBI View Article : Google Scholar
|
